https://www.avient.com/sites/default/files/resources/Innovation_Day_-_May_2014_0.pdf
Dodd Vice President Marketing Prototyping Services Design Support Fused Deposition Modeling Consumer Healthcare Aerospace Packaging Transportation 4) Enhanced Ergonomic Technologies Craig M.
VP / President Global Specialty Engineered Materials Versaflex™ VDT Thermoplastic Elastomers Healthcare Electrical & Electronics Consumer 1) Anti-Counterfeiting Solutions John V.
VP / President Global Color Additives and Inks Percept™ Authentication Technologies Healthcare Packaging Electrical & Electronics Consumer Transportation 2) Security and Safety Solutions Julie A.
https://www.avient.com/sites/default/files/2021-03/avient-march-ir-fermium_0.pdf
We partner with Brand Owners / OEMs, processors and assemblers to enable their goals in applications like packaging, healthcare, consumer goods, transportation, wire & cable, building & construction and textiles.
We will do so though our investments and focus on sustainable solutions for high-growth markets, including healthcare, consumer, packaging and composites/5G.
SEGMENT HIGHLIGHTS U.S. & Canada 50% EMEA 26% Asia 16% Latin America 8% 2020 SEGMENT, END MARKET AND GEOGRAPHY 29 GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 23% Packaging 21%Industrial 15% Wire & Cable 6% Building & Construction 6% Electrical & Electronics 4% END MARKET REVENUE Transportation 10% Healthcare 15% All data reflects 2020 Pro forma for acquisition of the Clariant Masterbatch business. (1) The total company sales and EBITDA of $3,783M and $457M, respectively, include intercompany sales eliminations and corporate costs $2,043M $331M $709M $124M $1,110M $70M Sales EBITDA Distribution Specialty Engineered Materials Color Additives and Inks $457M$3,783M (1) Packaging 35% Consumer 23% Healthcare 8% Industrial 14% Building & Construction 8% Transportation 7% Wire & Cable 3% Electrical & Electronics 2% C O L O R , A D D I T I V E S & I N K S 2020 PF REVENUE | $2 .0 BILLION US & Canada 31% EMEA 40% Asia 22% Latin America 7% END MARKET REGION 30 2020 figures Pro forma for acquisition of the Clariant Masterbatch business S P E C I A LT Y E N G I N E E R E D M AT E R I A L S Consumer 24% Healthcare 10% Packaging 6% Wire & Cable(1) 24% Electrical & Electronics 13% Transportation 11% Industrial 10% Building & Construction 2% 2020 REVENUE | $709 MILLION END MARKET US & Canada 58% EMEA 23% Asia 19% REGION 31 (1) Approximately 50% of Wire and Cable sales are associated with Fiber Optic Cabling DI S TR IBU T I ON 2020 REVENUE | $1 .1 B ILL ION Healthcare 29% Consumer 25% Packaging 2% Industrial 20% Transportation 14% Electrical & Electronics 5% Building & Construction 4% Wire & Cable 1% US & Canada 82% Asia 3% Latin America 15% END MARKET REGION K E Y S U P P L I ER S 32 AMERICAS EMEA ASIA Consumer 26% Healthcare 19% Packaging 13% Industrial 16% Wire & Cable 7% Building & Construction 5% Electrical & Electronics 4% Packaging 34% Consumer 16%Healthcare 5% Industrial 17% Wire & Cable 10% Building & Construction 8% Electrical & Electronics 3% Packaging 32% Consumer 27% Healthcare 12% Industrial 6% Wire & Cable 6% Building & Construction 4% Electrical & Electronics 9% Transportation 10% Transportation 7% Transportation 4% 2020 figures Pro forma for acquisition of the Clariant Masterbatch business TOTA L C O M PA N Y R E G I O N A L S A L E S BY END MARKET (58% of sales) (26% of sales) (16% of sales) 33
https://www.avient.com/sites/default/files/2025-05/AVNT Q1 2025 Webcast Slides_w_non-GAAP.pdf
FX) as strong growth in healthcare applications was offset by weak transportation demand, as well as lower defense sales on tough year over year comparisons • Unfavorable mix related to lower defense sales resulted in lower margin in the quarterAdj.
All Rights Reserved 2025 Color, Additives & Inks END MARKETS REGIONS 34% 21% 15% 11% 9% 8% Packaging Telecom 1%Energy 1% Transportation Industrial Consumer 34% 37% 20% 9% US & Canada Latin America Asia Europe, Middle East and Africa Healthcare Building & Construction 15Copyright © .
All Rights Reserved 2025 Specialty Engineered Materials END MARKETS REGIONS 20% 17% 14%13% 9% 9% 7% 7% 4% Defense Packaging Telecom Building & construction Transportation Industrial Consumer 54% 33% 13% US & Canada Asia Europe, Middle East and Africa Energy Healthcare Copyright © .
https://www.avient.com/sites/default/files/2025-08/AVNT Q2 2025 webcast slides_w_non_GAAP.pdf
EBITDA 64 63 Q2 2024 Q2 2025 • Strong growth in defense and healthcare sales partially offset by weak consumer demand • Productivity initiatives and cost controls more than offset by planned maintenance and investment in growth vectors resulting in lower margin in the quarterAdj.
All Rights Reserved 2025 Color, Additives & Inks END MARKETS REGIONS 34% 21% 15% 11% 9% 8% Packaging Telecom 1%Energy 1% Transportation Industrial Consumer 34% 37% 20% 9% US & Canada Latin America Asia Europe, Middle East and Africa Healthcare Building & Construction 15Copyright © .
All Rights Reserved 2025 Specialty Engineered Materials END MARKETS REGIONS 20% 17% 14%13% 9% 9% 7% 7% 4% Defense Packaging Telecom Building & construction Transportation Industrial Consumer 54% 33% 13% US & Canada Asia Europe, Middle East and Africa Energy Healthcare Copyright © .
https://www.avient.com/sites/default/files/2025-03/Q4 2024 Avient Webcast Slides w Non-GAAP.pdf
EBITDA 224 249 FY 2023 FY 2024 • Growth headlined by strong demand for applications in defense end market and composites used in building & construction and engineered materials used in healthcare • Adjusted EBITDA margin expansion driven by higher sales and favorable mix EXCL.
All Rights Reserved 2025 Color, Additives & Inks END MARKETS REGIONS 34% 21% 15% 11% 9% 8% Packaging Telecom 1%Energy 1% Transportation Industrial Consumer 34% 37% 20% 9% US & Canada Latin America Asia Europe, Middle East and Africa Healthcare Building & Construction 21Copyright © .
All Rights Reserved 2025 Specialty Engineered Materials END MARKETS REGIONS 20% 17% 14%13% 9% 9% 7% 7% 4% Defense Packaging Telecom Building & construction Transportation Industrial Consumer 54% 33% 13% US & Canada Asia Europe, Middle East and Africa Energy Healthcare Copyright © .
https://www.avient.com/sites/default/files/2025-05/AVNT Q1 2025 webcast slides_v17.pdf
FX) as strong growth in healthcare applications was offset by weak transportation demand, as well as lower defense sales on tough year over year comparisons • Unfavorable mix related to lower defense sales resulted in lower margin in the quarterAdj.
All Rights Reserved 2025 Color, Additives & Inks END MARKETS REGIONS 34% 21% 15% 11% 9% 8% Packaging Telecom 1%Energy 1% Transportation Industrial Consumer 34% 37% 20% 9% US & Canada Latin America Asia Europe, Middle East and Africa Healthcare Building & Construction 15Copyright © .
All Rights Reserved 2025 Specialty Engineered Materials END MARKETS REGIONS 20% 17% 14%13% 9% 9% 7% 7% 4% Defense Packaging Telecom Building & construction Transportation Industrial Consumer 54% 33% 13% US & Canada Asia Europe, Middle East and Africa Energy Healthcare Copyright © .
https://www.avient.com/sites/default/files/2024-02/CCG Mini Case Study_ 3D Dental Scanner_0.pdf
All Rights Reserved https://www.avient.com/products/polymer-colorants/high-temperature-color-concentrates/colorant-chromatics-transcend-premier-healthcare-colorants
https://www.avient.com/sites/default/files/2021-10/dynaflex-knee-brace-case-study-one-pager.pdf
HEALTHCARE DEVICE MANUFACTURER W E B K N E E B R A C E • Good bonding to polypropylene (PP) • Flexible and soft-touch feel • Skin contact, general FDA compliance • Good tensile strength and resilience • Excellent colorability • Offered material that passed the required FDA regulations • Provided high elasticity memory and ultra soft tactile finish to meet the comfort and pleasant surface feeling requirements • Delivered TPE with easy and stable processing and colorability DynaflexTM Thermoplastics Elastomer KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2020-07/case-study-one-pager-dynaflex-medical-face-mask.pdf
EUROPEAN MEDICAL DEVICE MANUFACTURER F A C E M A S K V E N T I L A T I O N V A L V E • ISO 9001 and USP VI compliant • Compatible with overmolding onto PP • Translucent and highly colorable • Soft touch • Provided valuable regulatory support and documentation, enabling faster internal trials and material qualification for this customer • Worked together with customer to select the best material from a broad portfolio of medical TPE grades • Trusted as a polymer supplier for multiple healthcare applications Dynaflex™ G2711 Thermoplastic Elastomer KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2025-06/NEUSoft-Catheter-case study snapshot.pdf
All Rights Reserved. https://www.avient.com/products/vivo-formulations-healthcare/neusoft-thermoplastic-polyurethanes Slide 1: Medical device Manufacturer